• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒辅助分析动脉内皮结构在动脉粥样硬化进展和代谢治疗中的变化。

Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy.

机构信息

Experimental Vascular Biology, Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS) , Amsterdam University Medical Center , Amsterdam 1105 AZ , The Netherlands.

Vascular Microenvironment and Integrity, Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS) , Amsterdam University Medical Center , Amsterdam 1105 AZ , The Netherlands.

出版信息

ACS Nano. 2019 Dec 24;13(12):13759-13774. doi: 10.1021/acsnano.8b08875. Epub 2019 Jul 10.

DOI:10.1021/acsnano.8b08875
PMID:31268670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6933811/
Abstract

Atherosclerosis is associated with a compromised endothelial barrier, facilitating the accumulation of immune cells and macromolecules in atherosclerotic lesions. In this study, we investigate endothelial barrier integrity and the enhanced permeability and retention (EPR) effect during atherosclerosis progression and therapy in mice using hyaluronan nanoparticles (HA-NPs). Utilizing ultrastructural and plaque imaging, we uncover a significantly decreased junction continuity in the atherosclerotic plaque-covering endothelium compared to the normal vessel wall, indicative of disrupted endothelial barrier. Intriguingly, the plaque advancement had a positive effect on junction stabilization, which correlated with a 3-fold lower accumulation of administrated HA-NPs in advanced plaques compared to early counterparts. Furthermore, by using super-resolution and correlative light and electron microscopy, we trace nanoparticles in the plaque microenvironment. We find nanoparticle-enriched endothelial junctions, containing 75% of detected HA-NPs, and a high HA-NP accumulation in the endothelium-underlying extracellular matrix, which suggest an endothelial junctional traffic of HA-NPs to the plague. Finally, we probe the EPR effect by HA-NPs in the context of metabolic therapy with a glycolysis inhibitor, 3PO, proposed as a vascular normalizing strategy. The observed trend of attenuated HA-NP uptake in aortas of 3PO-treated mice coincides with the endothelial silencing activity of 3PO, demonstrated Interestingly, the therapy also reduced the plaque inflammatory burden, while activating macrophage metabolism. Our findings shed light on natural limitations of nanoparticle accumulation in atherosclerotic plaques and provide mechanistic insight into nanoparticle trafficking across the atherosclerotic endothelium. Furthermore, our data contribute to the rising field of endothelial barrier modulation in atherosclerosis.

摘要

动脉粥样硬化与内皮屏障受损有关,这促进了免疫细胞和大分子在动脉粥样硬化病变中的积累。在这项研究中,我们使用透明质酸纳米颗粒(HA-NPs)在小鼠中研究动脉粥样硬化进展和治疗过程中的内皮屏障完整性和增强的通透性和保留(EPR)效应。通过超微结构和斑块成像,我们发现与正常血管壁相比,斑块覆盖的内皮中的连接连续性明显降低,表明内皮屏障受损。有趣的是,斑块进展对连接的稳定性有积极影响,这与晚期斑块中 HA-NPs 的积累量比早期斑块低 3 倍相关。此外,通过使用超分辨率和相关的光和电子显微镜,我们追踪斑块微环境中的纳米颗粒。我们发现富含纳米颗粒的内皮连接,其中包含 75%检测到的 HA-NPs,并且在血管内皮细胞下的细胞外基质中 HA-NP 大量积累,这表明 HA-NPs 通过内皮连接向斑块的运输。最后,我们在代谢治疗的背景下用糖酵解抑制剂 3PO 研究了 HA-NPs 的 EPR 效应,3PO 被提议作为一种血管正常化策略。观察到的 3PO 处理小鼠主动脉中 HA-NP 摄取减少的趋势与 3PO 的内皮沉默活性一致,有趣的是,该治疗还减少了斑块的炎症负担,同时激活了巨噬细胞代谢。我们的发现揭示了纳米颗粒在动脉粥样硬化斑块中积累的自然局限性,并为纳米颗粒穿过动脉粥样硬化内皮的运输提供了机制见解。此外,我们的数据为动脉粥样硬化中内皮屏障调节这一日益兴起的领域做出了贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/68addb00ef3d/nn8b08875_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/d48a4a8935b0/nn8b08875_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/9974dabc38be/nn8b08875_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/b3ecef86b2cb/nn8b08875_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/68addb00ef3d/nn8b08875_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/d48a4a8935b0/nn8b08875_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/9974dabc38be/nn8b08875_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/b3ecef86b2cb/nn8b08875_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0029/6933811/68addb00ef3d/nn8b08875_0004.jpg

相似文献

1
Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy.纳米颗粒辅助分析动脉内皮结构在动脉粥样硬化进展和代谢治疗中的变化。
ACS Nano. 2019 Dec 24;13(12):13759-13774. doi: 10.1021/acsnano.8b08875. Epub 2019 Jul 10.
2
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.透明质酸纳米颗粒选择性靶向斑块相关巨噬细胞并改善动脉粥样硬化斑块稳定性。
ACS Nano. 2017 Jun 27;11(6):5785-5799. doi: 10.1021/acsnano.7b01385. Epub 2017 May 15.
3
Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in -deficient mice.胰岛素样生长因子-1 受体内皮缺失导致内皮屏障功能降低,并促进 - 缺陷小鼠的动脉粥样硬化形成。
Am J Physiol Heart Circ Physiol. 2020 Oct 1;319(4):H730-H743. doi: 10.1152/ajpheart.00064.2020. Epub 2020 Aug 14.
4
Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice.部分抑制糖酵解可减少小鼠斑块内新生血管形成,从而减少动脉粥样硬化的发生。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1168-1181. doi: 10.1161/ATVBAHA.119.313692. Epub 2020 Mar 19.
5
Nanotherapeutic Shots through the Heart of Plaque.纳米治疗直击斑块要害。
ACS Nano. 2020 Feb 25;14(2):1236-1242. doi: 10.1021/acsnano.0c00245. Epub 2020 Jan 27.
6
Diverse ultrastructural landscape of atherosclerotic endothelium.动脉粥样硬化内皮的多种超微结构景观。
Atherosclerosis. 2021 Dec;339:35-45. doi: 10.1016/j.atherosclerosis.2021.11.017. Epub 2021 Nov 19.
7
Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice.抗 JNK2 肽-siRNA 纳米结构改善动脉粥样硬化小鼠斑块内皮并降低血栓形成风险。
Int J Nanomedicine. 2018 Sep 6;13:5187-5205. doi: 10.2147/IJN.S168556. eCollection 2018.
8
Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.透明质酸共轭阿托伐他汀纳米粒靶向给药有效抑制动脉粥样硬化斑块炎症
Nanoscale. 2020 May 7;12(17):9541-9556. doi: 10.1039/d0nr00308e.
9
Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.内皮细胞衍生的血管生成素样蛋白 2 在血管炎症导致内皮功能障碍和动脉粥样硬化进展中的作用。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.
10
Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.用半渗透纳米粒子对比剂定量研究晚期动脉粥样硬化中血管屏障破坏的演变。
PLoS One. 2011;6(10):e26385. doi: 10.1371/journal.pone.0026385. Epub 2011 Oct 18.

引用本文的文献

1
Recent Advances in Nanozymes for the Treatment of Atherosclerosis.用于治疗动脉粥样硬化的纳米酶的最新进展
Int J Nanomedicine. 2025 Jul 29;20:9447-9472. doi: 10.2147/IJN.S540010. eCollection 2025.
2
The role of cell junctions in atherosclerosis: implications for inflammation, endothelial dysfunction, and plaque stability.细胞连接在动脉粥样硬化中的作用:对炎症、内皮功能障碍和斑块稳定性的影响。
J Physiol Biochem. 2025 Jul 4. doi: 10.1007/s13105-025-01106-6.
3
Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression.

本文引用的文献

1
Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance.利用髓系细胞特异性纳米生物制剂抑制炎症反应可促进器官移植的接受。
Immunity. 2018 Nov 20;49(5):819-828.e6. doi: 10.1016/j.immuni.2018.09.008. Epub 2018 Nov 6.
2
Application of hyaluronic acid as carriers in drug delivery.透明质酸作为载体在药物传递中的应用。
Drug Deliv. 2018 Nov;25(1):766-772. doi: 10.1080/10717544.2018.1450910.
3
Sensing of Cytoskeletal Forces by Asymmetric Adherens Junctions.细胞骨架力的不对称黏着连接检测。
溶酶体锌纳米调节可阻断巨噬细胞焦亡以对抗动脉粥样硬化进展。
Sci Adv. 2025 Jun 27;11(26):eadu3919. doi: 10.1126/sciadv.adu3919. Epub 2025 Jun 25.
4
Essential information about nanotechnology in cardiology.心脏病学中纳米技术的基本信息。
Ann Med Surg (Lond). 2025 Jan 31;87(2):748-779. doi: 10.1097/MS9.0000000000002867. eCollection 2025 Feb.
5
High-Density Lipoprotein Biomimetic Inorganic-Organic Composite Nanosystem for Atherosclerosis Therapy.用于动脉粥样硬化治疗的高密度脂蛋白仿生无机-有机复合纳米系统
Polymers (Basel). 2025 Feb 26;17(5):625. doi: 10.3390/polym17050625.
6
Dual-mode-driven nanomotors targeting inflammatory macrophages for the MRI and synergistic treatment of atherosclerosis.用于磁共振成像及协同治疗动脉粥样硬化的靶向炎症巨噬细胞的双模式驱动纳米马达
J Nanobiotechnology. 2025 Jan 29;23(1):54. doi: 10.1186/s12951-025-03136-0.
7
Platelet membrane decorated exosomes enhance targeting efficacy and therapeutic index to alleviate arterial restenosis.血小板膜修饰的外泌体可提高靶向效果和治疗指数,以减轻动脉再狭窄。
Theranostics. 2025 Jan 1;15(2):408-427. doi: 10.7150/thno.103747. eCollection 2025.
8
Glucose Metabolism Reprogramming of Vascular Endothelial Cells and Its Implication in Development of Atherosclerosis.血管内皮细胞的葡萄糖代谢重编程及其在动脉粥样硬化发生发展中的意义。
Rev Cardiovasc Med. 2024 Nov 22;25(11):423. doi: 10.31083/j.rcm2511423. eCollection 2024 Nov.
9
Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy.纳米颗粒作为心血管疾病诊断和治疗的新平台。
Int J Nanomedicine. 2024 Aug 27;19:8831-8846. doi: 10.2147/IJN.S474888. eCollection 2024.
10
Targeted Delivery of Nanoparticles to Blood Vessels for the Treatment of Atherosclerosis.纳米颗粒靶向递送至血管用于治疗动脉粥样硬化
Biomedicines. 2024 Jul 6;12(7):1504. doi: 10.3390/biomedicines12071504.
Trends Cell Biol. 2018 Apr;28(4):328-341. doi: 10.1016/j.tcb.2017.11.002. Epub 2017 Nov 28.
4
Mechanisms of erosion of atherosclerotic plaques.动脉粥样硬化斑块侵蚀的机制。
Curr Opin Lipidol. 2017 Oct;28(5):434-441. doi: 10.1097/MOL.0000000000000440.
5
Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging.基于纳米颗粒的荧光分子成像评估显示,易发生血栓形成的动脉粥样硬化斑块在体内存在内皮通透性受损的情况。
Circ Cardiovasc Imaging. 2017 May;10(5). doi: 10.1161/CIRCIMAGING.116.005813.
6
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.透明质酸纳米颗粒选择性靶向斑块相关巨噬细胞并改善动脉粥样硬化斑块稳定性。
ACS Nano. 2017 Jun 27;11(6):5785-5799. doi: 10.1021/acsnano.7b01385. Epub 2017 May 15.
7
Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.Cu-MM-302 正电子发射断层扫描定量分析了转移性乳腺癌患者治疗反应相关的纳米颗粒增强通透性和滞留的变异性。
Clin Cancer Res. 2017 Aug 1;23(15):4190-4202. doi: 10.1158/1078-0432.CCR-16-3193. Epub 2017 Mar 15.
8
Vessel pruning or healing: endothelial metabolism as a novel target?血管修剪或修复:内皮细胞代谢作为一个新靶点?
Expert Opin Ther Targets. 2017 Mar;21(3):239-247. doi: 10.1080/14728222.2017.1282465. Epub 2017 Jan 27.
9
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?利用肿瘤微环境:既然 EPR 效应在临床上失败了,那么纳米医学的未来在哪里?
J Control Release. 2016 Dec 28;244(Pt A):108-121. doi: 10.1016/j.jconrel.2016.11.015. Epub 2016 Nov 18.
10
Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.抑制内皮细胞中的糖酵解激活剂PFKFB3可诱导肿瘤血管正常化、削弱转移并改善化疗。
Cancer Cell. 2016 Dec 12;30(6):968-985. doi: 10.1016/j.ccell.2016.10.006. Epub 2016 Nov 17.